Science Explorer Interactive view Map
Research facility · Évry-Courcouronnes · France

Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques

Research works
98
▲ 3% vs 2013–17
Citations
2.8k
29.1 per fractional work
Top-10% rate
16.3%
record average 16.5%
Open access
62%
world 28%

Not ranked overall: Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.06× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 9.41× its world share, 10 worksBiochemistry, Geneti…Immunology and Microbiology: 1.04× its world share, 0 worksImmunology and Micro…Neuroscience: 5.09× its world share, 2 worksNeuroscienceEnergy: 0.24× its world share, 0 worksEnergyEngineering: 0.23× its world share, 1 worksEngineeringEnvironmental Science: 0.35× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.07× its world share, 0 worksMaterials ScienceMathematics: 0.74× its world share, 0 worksMathematicsPhysics and Astronomy: 0.01× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.17× its world share, 0 worksHealth ProfessionsMedicine: 1.36× its world share, 5 worksMedicineNursing: 0.72× its world share, 0 worksNursingArts and Humanities: 1.01× its world share, 1 worksArts and HumanitiesPsychology: 0.58× its world share, 0 worksPsychologySocial Sciences: 0.16× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 9.4×. Every wedge is a field page.

Which keywords describe research at Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques?

By fractional works in all years, weighted toward what it does more of than the world: Differentiation, Pluripotent Stem Cells, Transcriptional Regulation, Embryonic Stem Cells, Induced Pluripotent Stem Cells, Reprogramming, Genome Engineering and RNA-Guided.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Differentiation15▲ 208×2 topics
  2. Pluripotent Stem Cells15▲ 217×2 topics
  3. Transcriptional Regulation14▲ 56×5 topics
  4. Embryonic Stem Cells14▲ 189×2 topics
  5. Induced Pluripotent Stem Cells13▲ 385×1 topic
  6. Reprogramming13▲ 385×1 topic
  7. Genome Engineering7▲ 125×1 topic
  8. RNA-Guided7▲ 125×1 topic
  9. Regenerative Medicine6▲ 26×4 topics
  10. Mitochondrial Dysfunction4▲ 13×7 topics
  11. Stem Cells4▲ 13×9 topics
  12. Gene Therapy3▲ 13×4 topics
  13. Cancer3▲ 2.3×16 topics
  14. Regeneration3▲ 18×3 topics
  15. Chaperones3▲ 46×2 topics
  16. Protein Aggregation3▲ 37×2 topics
  17. Huntington's Disease3▲ 81×1 topic
  18. Macular Degeneration3▲ 23×3 topics
  19. Polyglutamine3▲ 81×1 topic
  20. Clinical Trials3▲ 4.2×2 topics
  21. Ethical Issues3▲ 28×2 topics
  22. Brain Development2▲ 13×4 topics
  23. Genetic Mutations2▲ 4.8×11 topics
  24. Regulatory Challenges2▲ 33×1 topic
  25. Stem Cell Regulation2▲ 113×1 topic
  26. Electrical Stimulation2▲ 38×2 topics
  27. Gene Expression2▲ 4.0×9 topics
  28. Retinal Stem Cells2▲ 60×1 topic
  29. Retinitis Pigmentosa2▲ 60×1 topic
  30. Mesenchymal Stem Cells2▲ 19×2 topics
  31. Electrode Arrays2▲ 38×1 topic
  32. Immunomodulation2▲ 14×2 topics
  33. Neural Stimulation2▲ 38×1 topic
  34. Muscle Regeneration2▲ 57×1 topic
  35. Skeletal Muscle Atrophy2▲ 57×1 topic
  36. Multipotent2▲ 50×1 topic
  37. Stromal Cells2▲ 22×2 topics
  38. Therapeutic2▲ 24×1 topic
  39. Extracellular Matrix2▲ 7.4×4 topics
  40. Cell Culture2▲ 16×2 topics

Which research topics does Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques publish most on?

By volume in 2022–2025: Pluripotent Stem Cells Research, Muscle Physiology and Disorders, CRISPR and Genetic Engineering and Biochemical and Molecular Research.

  1. 1 Pluripotent Stem Cells Research Molecular Biology 2 works
  2. 2 Muscle Physiology and Disorders Molecular Biology 1 works
  3. 3 CRISPR and Genetic Engineering Molecular Biology 1 works
  4. 4 Biochemical and Molecular Research Molecular Biology 1 works
  5. 5 Cytomegalovirus and herpesvirus research Epidemiology 0 works
  6. 6 Genetics and Neurodevelopmental Disorders Genetics 0 works
  7. 7 Neurogenetic and Muscular Disorders Research Genetics 0 works
  8. 8 Wound Healing and Treatments Rehabilitation 0 works
  9. 9 Skin and Cellular Biology Research Cell Biology 0 works
  10. 10 Cardiomyopathy and Myosin Studies Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available62.3%not open37.7%

World: 28% of research is openly available.

with international co-authors21.5%domestic only78.5%

World: 19% is written across borders.

How has Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques's research output changed?

Output in 2018–2022 was 3% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Évry-Courcouronnes

All research institutions in Évry-Courcouronnes

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.